LET’S TALK
ABOUT TREMFYA®

7 out of 10 patients saw 90% clearer skin at 16 weeks. Patients saw improvement in symptoms such as burning, stinging, and itching. Results may vary.

Uncover results

If you've tried it all for your moderate to severe plaque psoriasis—like steroids, topical creams, or phototherapy—it’s time to talk to your doctor about TREMFYA®.

Uncover more about TREMFYA®

Only you and your doctor can decide if TREMFYA® is right for you.

RESULTS

Clearer Skin That Can Last

In clinical studies, at 16 weeks, at least 7 out of 10 patients saw at least 90% clearer skin, and more than 8 out of 10 were rated clear or almost clear.

In a clinical study, nearly 9 out of 10 patients who saw 90% clearer skin at 28 weeks continued to see 90% clearer skin at 48 weeks.

5-Year Results

In a study, nearly 7 out of 10 patients with 90% clearer skin at 16 weeks were still clearer at 5 years.
At 1 year and thereafter, patients and healthcare providers knew that TREMFYA® was being used. This may have increased results. Results may vary.

Clear Skin

In one clinical study, 5 out of 10 patients saw completely clear skin.

Clearer Scalp

In clinical studies at 16 weeks, 4 out of 5 patients with scalp psoriasis were rated clear or almost clear of their scalp psoriasis.

Superior Skin Clearance

In clinical studies, TREMFYA® worked better than Humira® (adalimumab) at providing significantly clearer skin.
Results are reflective of patients studied in the United States and Canada.

Humira® is a registered trademark of AbbVie Inc.

Fewer Symptoms

In clinical studies, more patients using TREMFYA® were free from symptoms, such as itching, pain, stinging, burning and skin tightness at 24 weeks compared with those using Humira®.

RESULTS YOU CAN SEE

WEEK 0

WEEK 48

Photos are of a real patient who received
TREMFYA® 100 mg at weeks 0, 4,
and then every 8 weeks.

BASELINE – WEEK 0
90% CLEARER SKIN – WEEK 48

Individual results may vary.

THE TREMFYA® TIMELINE: YEAR 1

Whether you’re waiting to get your prescription filled or are looking for an overview of treatment results seen with TREMFYA® in clinical studies, this timeline has the information you’re looking for.

STARTER DOSE WEEK 16 WEEK 28 WEEK 48

TREMFYA® is administered as a single 100 mg injection under the skin at weeks 0 and 4, and then every 8 weeks. It is administered by a healthcare provider or self-injected only after proper training.

I HAVE A PRESCRIPTION. WHAT HAPPENS NOW?

After your healthcare provider prescribes TREMFYA®, his or her office coordinator will confirm your insurance coverage.

WELCOME TO TREMFYA withMe

Once you and your doctor have decided that TREMFYA® is right for you, explore our support resources and see what we can do to help you get started.

For more on TREMFYA withMe,

CLICK HERE

TREMFYA withMe is limited to education about TREMFYA®, its administration, and/or the condition it treats. It is not intended to provide medical advice, replace a treatment plan you receive from your doctor or nurse, or serve as a reason for you to start or stay on treatment.

COST SUPPORT

Once you and your doctor have decided that TREMFYA® is right for you, TREMFYA withMe can help find programs that may help with your out-of-pocket costs for TREMFYA®.

LEARN MORE

THE FIRST STARTER DOSE

Your first injection may be performed at your dermatologist’s office, so he or she can make sure you’re properly trained to self-inject at home.

WATCH THE SELF-INJECTING VIDEO

THE SECOND STARTER DOSE

You’re on your way!

THE FIRST MAINTENANCE DOSE

Next one in 8 weeks!

GET CLEARER

After just 3 doses, 7 out of 10 patients saw at least 90% clearer skin, and more than 8 out of 10 were rated as clear or almost clear at 16 weeks in clinical studies.

After just 3 doses, 4 out of 5 patients with scalp psoriasis taking TREMFYA® during clinical studies were rated clear or almost clear at 16 weeks.

Individual results may vary.

THE SECOND MAINTENANCE DOSE